| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/10/2005 | CN1651456A Synthesis method of dipeptide containing L-glutamine |
| 08/10/2005 | CN1214040C Peptide derivatives having thiazolyl-alanine residue |
| 08/09/2005 | US6927290 Production of mixed acid anhydride and amide compound |
| 08/09/2005 | US6927236 For therapy of degenerative neuropathy, Alzheimer's disease |
| 08/04/2005 | WO2005070955A1 Macrocyclic peptides active against the hepatitis c virus |
| 08/04/2005 | WO2005070827A2 Fullerene based amino acids |
| 08/04/2005 | WO2005069894A2 Conformationally constrained smac mimetics and the uses thereof |
| 08/04/2005 | WO2005069888A2 Smac peptidomimetics and the uses thereof |
| 08/04/2005 | WO2005002516A3 Leukocyte internalized peptide-drug conjugates |
| 08/04/2005 | WO2005000880A3 Cytotoxic depsipeptides |
| 08/04/2005 | US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 08/04/2005 | US20050171146 Non-peptidic BRS-3 agonists |
| 08/04/2005 | US20050171137 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles |
| 08/04/2005 | US20050171059 Silanol enzyme inhibitors |
| 08/04/2005 | US20050171014 ligand, a linker, and a cytotoxic agent, in which the linker is FALA; cell-targeted cancer therapy |
| 08/04/2005 | US20050171011 Depsipeptide and congeners thereof for use as immunosuppressants |
| 08/04/2005 | US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders |
| 08/04/2005 | CA2553874A1 Conformationally constrained smac mimetics and the uses thereof |
| 08/04/2005 | CA2553871A1 Smac peptidomimetics and the uses thereof |
| 08/03/2005 | EP1559789A2 Method for producing dipeptide |
| 08/03/2005 | EP1558633A1 COMPOSITION FOR THE TREATMENT OF INFECTION BY i FLAVIVIRIDAE /i VIRUSES |
| 08/03/2005 | EP1558632A1 Macrocyclic peptides active against the hepatitis c virus |
| 08/03/2005 | EP1558630A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 08/03/2005 | CN1650024A Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 08/03/2005 | CN1649899A Connective tissue stimulating peptides |
| 08/03/2005 | CN1649893A Dipeptide derivatives having a N-terminal 2-thiocyl group as vasopeptidase inhibitors |
| 08/03/2005 | CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 08/03/2005 | CN1649840A Non-peptidic BRS-3 agonists |
| 08/03/2005 | CN1213067C Sequence number9 bioactive peptide |
| 08/03/2005 | CN1213066C Sequence number8 bioactive peptide |
| 08/03/2005 | CN1213065C Bioactive peptide No. 7 |
| 08/03/2005 | CN1213064C Bioactive peptide No. 28 |
| 08/03/2005 | CN1213063C Bioactive peptide No.12 |
| 08/03/2005 | CN1213062C Bioactive peptide No. 13 |
| 08/03/2005 | CN1213061C No.6 bioactive peptide |
| 08/03/2005 | CN1213060C No. 10 bioactive peptide |
| 08/03/2005 | CN1213058C FAP-activated anti-tumor compounds |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/03/2005 | CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors |
| 08/02/2005 | US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 07/28/2005 | WO2005068490A1 Inclusion complexes of perindopril |
| 07/28/2005 | WO2005068488A1 Method for synthesising peptidic compounds, in particular arginine residues-containing peptidic compounds on a solid support |
| 07/28/2005 | WO2005068425A1 New crystalline form of perindopril |
| 07/28/2005 | WO2005051410A9 Hepatitis c virus inhibitors |
| 07/28/2005 | WO2005044839A3 Stabilized alpha helical peptides and uses thereof |
| 07/28/2005 | WO2005017163A3 Phenotypic knockout of cell-surface proteins |
| 07/28/2005 | WO2004053093A3 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050165069 Statine derivatives for the treatment of Alzheimer's disease |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164963 Components for producing amphoteric liposomes |
| 07/28/2005 | US20050164953 Beta-secretase inhibitors |
| 07/28/2005 | US20050164950 Orally administered small peptides synergize statin activity |
| 07/28/2005 | US20050164921 7-Methoxy-2,4-disubstituted quinoline derivatives |
| 07/28/2005 | US20050164914 erectile dysfunction, and female sexual dysfunction; metallopeptide contains aromatic amino acid side chain moieties and does not bind any melanocortin receptor; combination therapy with phosphodiesterase inhibitor or melanocortin receptor MC4-R agonist |
| 07/28/2005 | US20050164311 Biological assay detection method |
| 07/28/2005 | US20050163084 Packet spread-spectrum transmitter |
| 07/28/2005 | DE10360435A1 New antibiotic peptides, useful in treating or preventing a microbial or viral infections or in inactivating Gram-positive and -negative bacteria, protozoa, fungi and virus |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/26/2005 | US6921806 Peptide |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/26/2005 | US6921751 Immunoregulator |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/26/2005 | US6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 07/26/2005 | CA2143823C Retro-, inverso - and retro-inverso synthetic peptide analogues |
| 07/21/2005 | WO2005066199A1 Method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and use thereof for the synthesis of perindopril |
| 07/21/2005 | WO2005066198A1 Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 07/21/2005 | WO2005066197A2 Inhibitors of methionine aminopeptidase-2 and uses thereof |
| 07/21/2005 | WO2005011607A3 Treatment of cancers expressing p95 erbb2 |
| 07/21/2005 | WO2004113365A3 Hepatitis c serine protease tri-peptide inhibitors |
| 07/21/2005 | US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides |
| 07/21/2005 | US20050159363 Selective neuronal nitric oxide synthase inhibitors |
| 07/21/2005 | US20050159362 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159346 Cyclic peptide antitumor agents |
| 07/21/2005 | US20050159345 Such as encephalitis and hepatitis |
| 07/21/2005 | US20050158838 Novel enterokinase cleavage sequences |
| 07/21/2005 | US20050158373 Method and carrier complexes for delivering molecules to cells |
| 07/21/2005 | DE10358824A1 Antibakterielle Makrozyklen mit substituiertem Biphenyl Antibacterial macrocycles with substituted biphenyl |
| 07/21/2005 | CA2550873A1 Inhibitors of methionine aminopeptidase-2 and uses thereof |
| 07/21/2005 | CA2548406A1 New process for synthesizing derivatives of (2s, 3as, 7as)-1-((s)- analyl)-octahydro-1h-in-dole-2-carboxylic acid and application to the synthesis of perindopril |
| 07/20/2005 | EP1555322A1 Lipolytic enzyme variant |
| 07/20/2005 | EP1554305A1 Prion protein-binding peptide sequences |
| 07/20/2005 | EP1554250A1 Novel lactams and uses thereof |
| 07/20/2005 | EP1554237A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1263774B1 Gamma-secretase inhibitors |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642975A Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 07/20/2005 | CN1642974A Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |